Sarcopenia(Small Molecule)
In-House
- Basic Research
- Candidate Discovery
- Preclinical Study
- Phase I
- Phase II
- Phase III
Using our proprietary sarcopenia biobank,Biobytes discovers biomarkers for drug development.

By integrating genomic and transcriptomic analysis,we prioritize evidence-based targets and maximize the potential for drug development success.
In-House
Joint Research
Joint Research
In-House
Biobank cohort data accelerates evidence-based drug development.
Contact Us